Clinical Trials

Showing trials with last updates posted in 2017.

NCT01419795 | TERMINATED | PHASE2
3 participants

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-27
Start Date:
2012-05-31
Completion:
2013-09-30
Conditions
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Angioimmunoblastic T-cell Lymphoma
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Hepatosplenic T-cell Lymphoma
  • Intraocular Lymphoma
  • Nodal Marginal Zone B-cell Lymphoma
  • Noncutaneous Extranodal Lymphoma
  • Peripheral T-cell Lymphoma
  • Prolymphocytic Leukemia
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
  • Recurrent Adult Grade III Lymphomatoid Granulomatosis
  • Recurrent Adult Immunoblastic Large Cell Lymphoma
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Adult T-cell Leukemia/Lymphoma
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Mycosis Fungoides/Sezary Syndrome
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Hairy Cell Leukemia
  • Small Intestine Lymphoma
  • Splenic Marginal Zone Lymphoma
  • T-cell Large Granular Lymphocyte Leukemia
  • Testicular Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
NCT01319851 | TERMINATED | NA
3 participants

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-27
Start Date:
2010-09-30
Completion:
2013-09-30
Conditions
  • Thalassemia
  • Sickle Cell Disease
  • Glanzmann Thrombasthenia
  • Wiskott-Aldrich Syndrome
  • Chronic-granulomatous Disease
  • Severe Congenital Neutropenia
  • Leukocyte Adhesion Deficiency
  • Schwachman-Diamond Syndrome
  • Diamond-Blackfan Anemia
  • Fanconi Anemia
  • Dyskeratosis-congenita
  • Chediak-Higashi Syndrome
  • Severe Aplastic Anemia
Interventions
  • DRUG
NCT01031186 | COMPLETED | PHASE1
20 participants

First Time in Human Study

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-27
Start Date:
2009-11-23
Completion:
2010-04-07
Conditions
  • Depressive Disorder and Anxiety Disorders
Interventions
  • DRUG
No Results Yet
NCT03223389 | UNKNOWN | NA
20 participants

Fat Metabolites and Gut Hormones

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-26
Start Date:
2017-08-07
Completion:
2018-12-31
Conditions
  • Overweight and Obesity
  • Type 2 Diabetes
  • Bariatric Surgery
  • Gut Hormones
  • Dietary Fat
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page